Chain of Custody in DOT Drug Testing: What It Is and Why Every Step Matters

In DOT drug testing, a positive result is not just a number on a lab report. It is a legal record that can affect a driver's livelihood, an employer's liability, and the outcome of an audit or court proceeding. The chain of custody is the process that makes that record defensible — and when it breaks down, even a legitimate positive test can be challenged and thrown out.

Understanding how chain of custody works, what each step requires, and where errors most commonly occur is important knowledge for any fleet operator, safety officer, or employer using DOT-regulated testing.

> Important: This article is for general information and is not legal advice. DOT and FMCSA requirements can change. Always review the latest guidance or consult a qualified compliance professional for your specific operation.

What Is Chain of Custody?

Chain of custody is a documented, unbroken sequence of events that tracks a biological specimen — in most DOT drug tests, a urine sample — from the moment it is collected to the moment a result is reported.

The purpose is to establish, at every step, who had control of the specimen, when, and under what conditions. If a specimen was ever handled in a way that is not documented and accounted for, the result can be disputed on the grounds that tampering, contamination, or substitution cannot be ruled out.

In DOT drug testing under 49 CFR Part 40, the Federal Drug Testing Custody and Control Form (CCF) is the official document used to track the specimen throughout the collection and laboratory process.

Step-by-Step: How Chain of Custody Works in a DOT Collection

**Step 1 — Donor identification** The collector verifies the donor's identity using a government-issued photo ID. The donor's name, date of birth, and employer information are recorded on the CCF. This step establishes who provided the specimen.

**Step 2 — Collection site setup and observation** The collection area is prepared to minimize the opportunity for adulteration or substitution. Bluing agents are placed in toilet water, and the donor is instructed to remove outer garments and leave personal belongings outside the collection area. In some circumstances, a directly observed collection is required.

**Step 3 — Specimen collection and temperature check** The donor provides the specimen in a single-use collection container. The temperature of the specimen is immediately checked and recorded — a specimen outside the acceptable temperature range raises a flag that must be documented.

**Step 4 — Specimen split and sealing** The collector splits the specimen into two bottles: the primary specimen (Bottle A) and the split specimen (Bottle B). Both are sealed with tamper-evident tape in the donor's presence, and the donor initials each seal to confirm the specimen is theirs and was sealed in their presence.

**Step 5 — CCF completion** The collector and the donor both sign and date the CCF. The collector's copy, the laboratory copy, and the employer copy are separated and distributed according to Part 40 requirements. Every box on the CCF must be completed correctly — missing fields are a documentation deficiency that can affect the result.

**Step 6 — Laboratory receipt and accessioning** When the specimen arrives at the certified laboratory, the receiving technician checks the packaging, the seals, and the CCF. Any discrepancy is documented. The specimen is logged into the laboratory information system and assigned an accession number that ties it to the original collection.

**Step 7 — Testing and Medical Review Officer review** The laboratory performs the initial screen and, if needed, a confirmatory test. Non-negative results are reviewed by a certified Medical Review Officer (MRO) who contacts the donor to determine whether a legitimate medical explanation exists before reporting the final result to the employer.

Where Chain of Custody Breaks Down

Chain-of-custody errors can occur at any stage. Common issues include:

• Failing to verify the donor's identity before collection
• Missing or incorrect information on the CCF
• Damaged or broken tamper-evident seals
• Specimen temperature outside the acceptable range without proper documentation
• Gaps in the transfer record between the collection site and the laboratory
• Incomplete MRO review before a result is reported to the employer

Any unexplained discrepancy gives a donor or their legal counsel grounds to challenge the result. For employers, this can mean a test result cannot be used as a basis for employment action — even when the specimen itself was positive.

Why Mobile Collection Matters for Chain of Custody

When a driver or employee travels to an unfamiliar clinic for testing, neither the employer nor the employee has visibility into how the collection is conducted. A mobile collection by a trained, experienced technician who follows the same documented process every time reduces the risk of procedural errors — and brings that consistency directly to your worksite or job site.

Sky Wings Transportation performs mobile DOT and non-DOT drug collections throughout metro Atlanta and surrounding counties, following the full 49 CFR Part 40 chain-of-custody process on every test. Our technicians are trained in proper CCF completion, specimen handling, and temperature documentation, so your results are accurate, compliant, and audit-ready.

To schedule a collection or set up a testing program for your company, call 229-348-8022 or email [email protected]. We serve employers and fleet operators throughout metro Atlanta and surrounding counties.